Intermittent preventive treatment of infants with mefloquine reduces risk of clinical malaria in areas of moderate malaria transmission and high resistance to sulphadoxine-pyrimethamine, but safety and tolerability issues need consideration.
| Hoofdauteur: | |
|---|---|
| Formaat: | Journal article |
| Taal: | English |
| Gepubliceerd in: |
2010
|